Skandinaviska Enskilda Banken Ab (Publ) Morphic Holding, Inc. Transaction History
Skandinaviska Enskilda Banken Ab (Publ)
- $20.3 Billion
- Q1 2024
A detailed history of Skandinaviska Enskilda Banken Ab (Publ) transactions in Morphic Holding, Inc. stock. As of the latest transaction made, Skandinaviska Enskilda Banken Ab (Publ) holds 13,984 shares of MORF stock, worth $476,434. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,984
Previous 13,984
-0.0%
Holding current value
$476,434
Previous $403,000
22.08%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding MORF
# of Institutions
142Shares Held
37.9MCall Options Held
13.5KPut Options Held
190K-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct4.69MShares$160 Million0.42% of portfolio
-
Wellington Management Group LLP Boston, MA4.02MShares$137 Million0.03% of portfolio
-
Black Rock Inc. New York, NY3.28MShares$112 Million0.0% of portfolio
-
State Street Corp Boston, MA2.67MShares$90.8 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.52MShares$86 Million0.01% of portfolio
About Morphic Holding, Inc.
- Ticker MORF
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,477,100
- Market Cap $1.31B
- Description
- Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...